Literature DB >> 4855829

Plasma half-life of phenylbutazone in patients with impaired liver function.

E F Hvidberg, P B Andreasen, L Ranek.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4855829     DOI: 10.1002/cpt1974152171

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  13 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Pharmacokinetics of diazepam in disordered liver function.

Authors:  P B Andreasen; J Hendel; G Greisen; E F Hvidberg
Journal:  Eur J Clin Pharmacol       Date:  1976-06-15       Impact factor: 2.953

3.  Disposition and oxidative metabolism of phenylbutazone in man.

Authors:  J Aarbakke; O M Bakke; E J Milde; D S Davies
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

Review 4.  Guide to drug dosage in hepatic disease.

Authors:  N M Bass; R L Williams
Journal:  Clin Pharmacokinet       Date:  1988-12       Impact factor: 6.447

Review 5.  Drug metabolism in liver disease.

Authors:  L F Prescott; J A Forrest; K K Adjepon-Yamoah; N D Finlayson
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1975

6.  Pharmacokinetics of phenylbutazone and oxyphenabutazone in the pig.

Authors:  E F Hvidberg; F Rasmussen
Journal:  Can J Comp Med       Date:  1975-01

7.  Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease.

Authors:  J A Forrest; N D Finlayson; K K Adjepon-Yamoah; L F Prescott
Journal:  Br Med J       Date:  1977-05-28

8.  Ascorbic acid deficiency in liver disease.

Authors:  A D Beattie; S Sherlock
Journal:  Gut       Date:  1976-08       Impact factor: 23.059

Review 9.  Drug prescribing in hepatobiliary disease.

Authors:  R K Roberts; P V Desmond; S Schenker
Journal:  Drugs       Date:  1979-03       Impact factor: 9.546

Review 10.  Clinical pharmacokinetics of phenylbutazone.

Authors:  J Aarbakke
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.